AP
ABBV icon

Atwood & Palmer’s AbbVie ABBV Stock Holding History

Atwood & Palmer’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.3M Buy
195,763
+1,615
+0.8% +$347K 2.63% 10
2026
Q1 		$42.2M Sell
194,148
-228
-0.1% -$50.6K 2.38% 10
2025
Q4 		$44.4M Buy
194,376
+3,524
+2% +$803K 2.52% 10
2025
Q3 		$44.2M Buy
190,852
+93
+0% +$18.9K 2.6% 10
2025
Q2 		$35.4M Sell
190,759
-589
-0.3% -$109K 2.21% 16
2025
Q1 		$40.1M Sell
191,348
-4,555
-2% -$886K 2.78% 5
2024
Q4 		$34.8M Buy
195,903
+2,377
+1% +$437K 2.39% 11
2024
Q3 		$38.2M Sell
193,526
-720
-0.4% -$134K 2.6% 11
2024
Q2 		$33.3M Buy
194,246
+3,815
+2% +$632K 2.52% 11
2024
Q1 		$34.7M Buy
190,431
+1,124
+0.6% +$194K 2.63% 10
2023
Q4 		$29.3M Sell
189,307
-449
-0.2% -$65.5K 2.37% 12
2023
Q3 		$28.3M Buy
189,756
+530
+0.3% +$77.8K 2.48% 11
2023
Q2 		$25.5M Buy
189,226
+3,145
+2% +$461K 2.28% 16
2023
Q1 		$29.7M Buy
186,081
+1,521
+0.8% +$233K 2.79% 8
2022
Q4 		$29.8M Buy
184,560
+2,173
+1% +$333K 2.7% 9
2022
Q3 		$24.5M Buy
182,387
+2,500
+1% +$359K 2.43% 11
2022
Q2 		$27.6M Buy
179,887
+17,251
+11% +$2.64M 2.68% 6
2022
Q1 		$26.4M Buy
162,636
+3,415
+2% +$496K 2.28% 16
2021
Q4 		$21.6M Buy
159,221
+818
+0.5% +$96.6K 1.8% 23
2021
Q3 		$17.1M Buy
158,403
+7,673
+5% +$877K 1.52% 31
2021
Q2 		$17M Buy
150,730
+11,184
+8% +$1.26M 1.53% 30
2021
Q1 		$15.1M Buy
139,546
+1,800
+1% +$193K 1.45% 30
2020
Q4 		$14.8M Buy
137,746
+10,121
+8% +$973K 1.58% 28
2020
Q3 		$11.2M Buy
127,625
+1,451
+1% +$137K 1.41% 29
2020
Q2 		$12.4M Buy
126,174
+123,364
+4,390% +$10.9M 1.67% 25
2020
Q1 		$214K Buy
2,810
+310
+12% +$26.4K 0.03% 113
2019
Q4 		$221K Hold
2,500
– – 0.03% 119
2019
Q3 		$189K Hold
2,500
– – 0.03% 128
2019
Q2 		$182K Hold
2,500
– – 0.02% 128
2019
Q1 		$201K Hold
2,500
– – 0.03% 121
2018
Q4 		$230K Sell
2,500
-600
-19% -$52.8K 0.04% 108
2018
Q3 		$293K Hold
3,100
– – 0.04% 108
2018
Q2 		$287K Sell
3,100
-1,250
-29% -$122K 0.04% 108
2018
Q1 		$412K Sell
4,350
-400
-8% -$43.9K 0.06% 88
2017
Q4 		$459K Hold
4,750
– – 0.06% 88
2017
Q3 		$422K Hold
4,750
– – 0.06% 89
2017
Q2 		$344K Buy
4,750
+2,600
+121% +$175K 0.05% 98
2017
Q1 		$140K Buy
2,150
+2,000
+1,333% +$126K 0.02% 131
2016
Q4 		$9K Buy
+150
New +$9.16K ﹤0.01% 269
2016
Q1 		– Sell
-324
Closed -$19K – 313
2015
Q4 		$19K Sell
324
-300
-48% -$17.3K ﹤0.01% 273
2015
Q3 		$34K Sell
624
-128
-17% -$8.33K 0.01% 218
2015
Q2 		$51K Buy
+752
New +$49.1K 0.01% 185
2015
Q1 		– Sell
-5,222
Closed -$342K – 324
2014
Q4 		$342K Hold
5,222
– – 0.06% 101
2014
Q3 		$302K Buy
5,222
+463
+10% +$25.7K 0.06% 103
2014
Q2 		$269K Sell
4,759
-612
-11% -$32.1K 0.07% 99
2014
Q1 		$276K Buy
5,371
+132
+3% +$6.67K 0.06% 100
2013
Q4 		$277K Hold
5,239
– – 0.07% 95
2013
Q3 		$234K Hold
5,239
– – 0.06% 99
2013
Q2 		$217K Buy
+5,239
New +$229K 0.06% 94

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Atwood & Palmer's ABBV Position: Q2 2026 in Review

Atwood & Palmer increased its AbbVie (ABBV) stake by 0.83% in Q2 2026, buying an estimated $347K and bringing the position to 195,763 shares worth $49.3M. The position accounts for 2.63% of the portfolio, ranked #10.

Atwood & Palmer first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atwood & Palmer held 195,763 shares of AbbVie worth $49.3M as of Q2 2026.
  • Atwood & Palmer bought 1,615 AbbVie shares in Q2 2026, an estimated $347K.
  • AbbVie made up 2.63% of Atwood & Palmer's portfolio in Q2 2026, its #10 holding.
  • Atwood & Palmer first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.